HDFC Pharma and Healthcare Fund - Direct (G) logo

HDFC Pharma and Healthcare Fund Direct Growth

NAV ₹18.03 as on 17 Nov 2025

RiskVery High

Fund Size₹1,966.73Cr

NAV₹18.03 as on 17 Nov 2025
RiskVery High
Fund Size₹1,966.73Cr

Download 3-in-1 Torus App
Trade at flat ₹11/order & Zero AMC
demat with one powerful SuperApp.

Investment Details
Top Rated Funds

Lock-in

No Lock-in

Min One Time Amount

₹100

Min Withdrawal Amount

₹-

Min SIP Amount

₹100

Min Additional Amount

₹100

Exit Load

In respect of each purchase/Switch-in of units, an Exit load of 1% is payable if units are redeemed/switched-out within 30 days from the date of allotment. No Exit Load is payable if units are redeemed / switched-out after 30 days from the date of allotment.

Basic Details

Age

2 years 1 months (Since Oct 04, 2023)

Return since Launch

32.00%

Expense ratio

0.92%

Type

OPEN

AUM (Fund Size)

₹1,966.73

Risk Grade

Very High

Benchmark

BSE Healthcare TRI

Calculate Your Returns
Select Duration
Choose Amount
Returns
Total investment of ₹2,40,000
Would have become ₹61,949 (+209.74%)
Fund Manager

Name:

Nikhil Mathur

Experience:

September 22, 2021 onwards HDFC Asset Management Company Limited July 26, 2017 to September 21, 2021 Ambit Capital India Pvt Ltd. Last Position Held: Vice President August 31, 2015 to July 25, 2017 Goldman Sachs (India) Securities Pvt Ltd. Last Position Held - Research Business Analyst September 8, 2014 to August 27, 2015 Deloitte Touche Tohmatsu India Private Ltd. Last Position Held - Assistant Manager June 17, 2013 to September 4, 2014 Ernst & Young LLP Last Position Held: Analyst

RiskometerLevel of risk in the scheme
Moderate
High
Low
Very
High

Your investment will be at Very High Risk

Fund house & investment objective
Rank (total assets)#3 in India
Total AUM₹8,93,027.76Cr
Date of Incorporation10 Dec 1999
HDFC Pharma and Healthcare Fund Direct Growth is a Equity Mutual Fund Scheme launched by HDFC Mutual Fund. This scheme was made available to investors on 04 Oct 2023. The fund currently has an Asset Under Management(AUM) of ₹8,93,027.76 Cr and the Latest NAV as of 17 Nov 2025 is ₹18.03.
The HDFC Pharma and Healthcare Fund Direct Growth is rated Very High. Minimum SIP Investment is set to ₹100 . Minimum Lumpsum Investment is ₹100. Exit load of In respect of each purchase/Switch-in of units, an Exit load of 1% is payable if units are redeemed/switched-out within 30 days from the date of allotment. No Exit Load is payable if units are redeemed / switched-out after 30 days from the date of allotment..
...Read more
Returns and Rankings

Category: Equity Sectoral / Thematic

1Y3Y5YAll
Fund returns12.12%--14.89%
Category average8.02%6.14%3.98%-
Rank within category5411995-

FAQ’s

What kind of returns does HDFC Pharma and Healthcare Fund Direct Growth provide?

HDFC Pharma and Healthcare Fund Direct Growth has given a return of NA% in the past 3 years.

What is the expense ratio charged by HDFC Pharma and Healthcare Fund Direct Growth?

The Expense Ratio charged by HDFC Pharma and Healthcare Fund Direct Growth is 0.92%.

What is the AUM size of HDFC Pharma and Healthcare Fund Direct Growth?

The AUM size of HDFC Pharma and Healthcare Fund Direct Growth is ₹1,966.73Cr.

What is the minimum SIP amount that you can invest in HDFC Pharma and Healthcare Fund Direct Growth?

₹100 is the minimum SIP amount that you can invest in HDFC Pharma and Healthcare Fund Direct Growth .

What are the top stock holdings of HDFC Pharma and Healthcare Fund Direct Growth?

The top stock holdings of HDFC Pharma and Healthcare Fund Direct Growth include , Sun Pharmaceutical Industries Ltd , Divis Laboratories Ltd , Lupin Ltd and Glenmark Pharmaceuticals Ltd.

Get started with us today and
start building your wealth journey

*By clicking, I agree to the T&C and Whatsapp updates.

Get started with us today and
start building your wealth journey

*By clicking, I agree to the T&C and Whatsapp updates.